N
Nadia Haj Mohammad
Researcher at Utrecht University
Publications - 88
Citations - 2331
Nadia Haj Mohammad is an academic researcher from Utrecht University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 17, co-authored 65 publications receiving 1341 citations. Previous affiliations of Nadia Haj Mohammad include University Medical Center Utrecht & University of Amsterdam.
Papers
More filters
Journal ArticleDOI
Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial.
Pieter C. van der Sluis,Sylvia van der Horst,Anne M. May,Carlo Schippers,Lodewijk A.A. Brosens,Hans C. A. Joore,Christiaan C. Kroese,Nadia Haj Mohammad,Stella Mook,Frank P. Vleggaar,Inne H.M. Borel Rinkes,Jelle P. Ruurda,Richard van Hillegersberg +12 more
TL;DR: Robot-assisted minimally invasive thoracolaparoscopic esophageal cancer treatment with RAMIE resulted in a lower percentage of overall surgery-related and cardiopulmonary complications with lower postoperative pain, better short-term quality of life, and a better long-term postoperative functional recovery compared to OTE.
Journal ArticleDOI
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2) : a multicentre, patient-blinded, randomised controlled phase 2/3 trial
Jony van Hilst,Thijs de Rooij,Koop Bosscha,David J. Brinkman,Susan van Dieren,Marcel G. W. Dijkgraaf,Michael F. Gerhards,Ignace H. J. T. de Hingh,Tom M. Karsten,D.J. Lips,D.J. Lips,Misha D. P. Luyer,Olivier R. Busch,Sebastiaan Festen,Marc G. Besselink,Hendrik A. Marsman,Thomas M. van Gulik,Dennis A. Wicherts,Wietse J. Eshuis,Luna A Stibbe,Els Jm Nieveen van Dijkum,Janine E Van Hooft,Paul Fockens,Hanneke W. M. van Laarhoven,Johanna W. Wilmink,Marcel J Van de Vijver,Maarten F. Bijlsma,Joanne Verheij,C. Yung Nio,Krijn P. van Lienden,Geertjan van Tienhoven,Annuska Schoorlemmer,Geert-Jan Creemers,Casper H.J. van Eijck,Bas Groot Koerkamp,Marco J. Bruno,Ferry A.L.M. Eskens,Joost J. Nuyttens,Chulja Pek,George P. van der Schelling,Tom C.J. Seerden,Gijs A. Patijn,Vincent B. Nieuwenhuijs,Jan Willem B. de Groot,Bert A. Bonsing,Alexander L. Vahrmeijer,R.-J. Swijnenburg,J. Sven D. Mieog,Erwin van der Harst,Matthijs Den Dulk,Steven W.M. Olde Damink,Cees H. Dejong,Ronald Van Dam,Judith Mpgm De Vos,Mike Sl Liem,Cees J. H. M. van Laarhoven,Harry van Goor,Peter B. van den Boezem,B. Marion van der Kolk,Martijn Wj Stommel,John J. Hermans,Erwin J M van Geenen,Sandra A Radema,Lodewijk A.A. Brosens,Joris J. Scheepers,Daphne Roos,Djamilla Boerma,Wouter W. te Riele,Hjalmar C. van Santvoort,Thomas L. Bollen,Fanny Wit,I. Quintus Molenaar,Nadia Haj Mohammad,Maarten S. van Leeuwen,Annemarie Roele,Kees P De Jong,Vincent E de Meijer,Joost M. Klaase,Geert Kazemier,Babs M Zonderhuis,Freek Daams,Martijn R. Meijerink,Anouk E J Latenstein,L. Bengt van Rijssen,Carolijn L.M.A. Nota,Emo Van Halsema,Eran van Veldhuisen,Jantien A. Vogel,Kiki Janssen,Lianne Scholten,Lois A. Daamen,Marieke S. Walma,Marin Strijker,Mariska Prins,Maurice J. W. Zwart,Mustafa Suker,Steffi J.E. Rombouts,Timothy H. Mungroop,F. Vissers,Maarten Korrel +99 more
TL;DR: This multicentre, patient-blinded, parallel-group, randomised controlled phase 2/3 trial was performed in four centres in the Netherlands to assess whether laparoscopic pancreatoduodenectomy could reduce time to functional recovery compared with open pancreatic fistula.
Journal ArticleDOI
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
Bo Jan Noordman,Manon C.W. Spaander,Roelf Valkema,Bas P. L. Wijnhoven,Mark I. van Berge Henegouwen,Joel Shapiro,Katharina Biermann,Ate van der Gaast,Richard van Hillegersberg,Maarten C.C.M. Hulshof,Kausilia K. Krishnadath,Sjoerd M. Lagarde,Grard A. P. Nieuwenhuijzen,Liekele E. Oostenbrug,Peter D. Siersema,Peter D. Siersema,Erik J. Schoon,Meindert N. Sosef,Ewout W. Steyerberg,Ewout W. Steyerberg,J. Jan B. van Lanschot,Michael Doukas,Nanda C. Krak,Jan-Werner Poley,Caroline M. van Rij,Jaques Jghm Bergman,Suzanne S. Gisbertz,Hanneke W. M. van Laarhoven,Sybren L. Meijer,Lucas Goense,Nadia Haj Mohammad,Monique G.G. Hobbelink,G. Johan A. Offerhaus,Frank P. Vleggaar,Wouter L. Curvers,Geert-Jan Creemers,Mark J. Roef,Maurice J.C. van der Sangen,Jeroen Buijsen,Robert G. Riedl,Wendy M. J. Schreurs,Fabiënne A. R. M. Warmerdam,Mjr Janssen,Chella Van Der Post,Sandra A Radema,Camiel Rosman,H.J.T. Rutten +46 more
TL;DR: The correlation between clinical response during clinical response evaluations and the final pathological response in resection specimens was shown, as shown by the proportion of tumour regression grade (TRG) 3 or 4 residual tumours that was missed duringclinical response evaluations.
Journal ArticleDOI
Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer
Steffi J.E. Rombouts,Marieke S. Walma,Jantien A. Vogel,Lennart B. van Rijssen,Johanna W. Wilmink,Nadia Haj Mohammad,Hjalmar C. van Santvoort,Quintus Molenaar,Marc G. Besselink +8 more
TL;DR: Outcomes after FOLFIRINOX-based therapy in patients with LAPC seem very promising but further prospective studies are needed, especially with regard to survival after resection.
Journal ArticleDOI
The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer : A Network Meta-analysis
Emil ter Veer,Nadia Haj Mohammad,Gert van Valkenhoef,Lok Lam Ngai,Rosa M A Mali,Maarten C. J. Anderegg,Martijn G.H. van Oijen,Hanneke W. M. van Laarhoven +7 more
TL;DR: Based on efficacy and toxicity, F-doublets FOx, FI, and FT are preferred as first-line treatment for AEGC compared with C- doublets, A-triplets, and TCF, and the triplet FOxT is the most promising triplet.